CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	50.23B
Revenue (ttm)	2.09B
Net Income (ttm)	-109.65M
Shares Out	1.39B
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	112.79
Dividend	0.02 (0.06%)
Ex-Dividend Date	May 29, 2025

Volume	21,448,093
Average Volume	18,221,598
Open	35.41
Previous Close	36.07
Day's Range	34.60 - 38.63
52-Week Range	22.02 - 63.31
Beta	0.31
RSI	54.72
Earnings Date	Mar 17, 2026

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 2,487
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2024, SHE:300765's revenue was 1.98 billion, a decrease of -21.98% compared to the previous year's 2.54 billion. Earnings were 53.73 million, a decrease of -87.63%.